99% Cefadroxil CAS 66592-87-8/Cefazolin Sodium CAS 27164-46-1/Cefotiam Hydrochloride CAS 66309-69-1/Ofloxacin CAS 82419 -36-1/CAS 64485-93-4 Cefotaxime Sodium

China 99% Cefadroxil CAS 66592-87-8/Cefazolin Sodium CAS 27164-46-1/Cefotiam Hydrochloride CAS 66309-69-1/Ofloxacin CAS 82419-36-1/CAS 64485-93-4 Cefotaxime Sodium, Find details about China Cefadroxil, CAS 66592-87-8 from 99% Cefadroxil CAS 66592-87-8/Cefazolin Sodium CAS 27164-46-1/Cefotiam Hydrochloride CAS 66309-69-1/Ofloxacin CAS 82419-36-1/CAS 64485-93-4 Cefotaxime Sodium

Basic Info.

Model NO.

Cefotaxime sodium

CAS

64485-93-4

C16h16n5nao7s2

477.45

Appearance

White Powder

Function

Veterinary Medicine Raw Materials

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Model NO.

Cefotaxime sodium

CAS

64485-93-4

C16h16n5nao7s2

477.45

Appearance

White Powder

Function

Veterinary Medicine Raw Materials

Shelf Life

2 Years

Test Method

HPLC UV

Storage

Cool Dry Place

Payment

Tt.Western Union .Credit Card.Moneygram

Delivery Time

Within 2 Days

Certificate

COA MSDS

Sample

Available

Trademark

Faithful

Transport Package

Aluminum Foil Bag Packaging

Specification

10g/bag; 100g/bag; 1kg/bag

Origin

China

Product Desciption

99% cefadroxil CAS 66592-87-8/cefazolin sodium CAS 27164-46-1/Cefotiam hydrochloride CAS 66309-69-1/Ofloxacin CAS 82419-36-1/CAS 64485-93-4 Cefotaxime sodium

Introduction

CAS NO :64485-93-4
MF:C16H16N5NaO7S2
EINECS No:264-915-9
Place of Origin: China (Mainland)
Assay:no less than 99%
Packaging Details:25kg drum
Appearance: This product is white, almost white or yellowish white crystalline powder; odorless or slight special smell. It is free soluble in water, slightly soluble in ethanol, insoluble in chloroform.

Function

Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease

Specification

Product Name	Cefotaxime Sodium Sterile
Package	6kg/tin, 2tins/carton
Appearance	White to slightly yellow crystal or powder
Solubility	Freely soluble in water; sparingly soluble in ethanol
Identification	Infrared-spectrometry:both spectra exhibit similar intensities of absorption at the same wave numbers It responds to the qualitative test of sodium salt The chromatogram of the Assay obtained as directed in the Assay exhibits a major peak for cefotaxime, the retention time of which corresponds to that exhibited in the chromatogram of the Standard preparation obtained as directed in the Assay
Specific rotation	+58°~ +64°
pH	4.5~6.5
Clarity of solution	Clear
Clarity of solution	Absorbance : ≤0.20
Loss on drying	≤3.0%
Particulate matter	≥10μm, ≤ 3000 ≥25μm, ≤ 300
Chromatographic purity	Any individual impurity: ≤1.0% Total impurities:≤3.0%
Bacterial endotoxins	Not more than 0.025 USP Endotoxin Unit per mg
Sterility	Should be sterile
Assay	916ug/mg~964ug/mg
Visible foreign matter	Essentially free from
Labeling	According to normative documentation